1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Pneumococcal Vaccine Consumption 2016-2026 2.1.2 Pneumococcal Vaccine Consumption CAGR by Region 2.2 Pneumococcal Vaccine Segment by Type 2.2.1 PPSV 23 2.2.2 PCV 7/13 2.2.3 PCV 10 2.3 Pneumococcal Vaccine Sales by Type 2.3.1 Global Pneumococcal Vaccine Sales Market Share by Type (2016-2021) 2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2016-2021) 2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2016-2021) 2.4 Pneumococcal Vaccine Segment by End User 2.4.1 Child 2.4.2 Adult 2.5 Pneumococcal Vaccine Sales by End User 2.5.1 Global Pneumococcal Vaccine Sale Market Share by End User (2016-2021) 2.5.2 Global Pneumococcal Vaccine Revenue and Market Share by End User (2016-2021) 2.5.3 Global Pneumococcal Vaccine Sale Price by End User (2016-2021) 3 Global Pneumococcal Vaccine by Company 3.1 Global Pneumococcal Vaccine Sales Market Share by Company 3.1.1 Global Pneumococcal Vaccine Sales by Company (2019-2021) 3.1.2 Global Pneumococcal Vaccine Sales Market Share by Company (2019-2021) 3.2 Global Pneumococcal Vaccine Revenue Market Share by Company 3.2.1 Global Pneumococcal Vaccine Revenue by Company (2019-2021) 3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2021) 3.3 Global Pneumococcal Vaccine Sale Price by Company 3.4 Global Manufacturers Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Pneumococcal Vaccine Product Location Distribution 3.4.2 Players Pneumococcal Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Pneumococcal Vaccine by Region 4.1 Global Pneumococcal Vaccine by Region 4.1.1 Global Pneumococcal Vaccine Sales by Region 4.1.2 Global Pneumococcal Vaccine Revenue by Region 4.2 Americas Pneumococcal Vaccine Sales Growth 4.3 APAC Pneumococcal Vaccine Sales Growth 4.4 Europe Pneumococcal Vaccine Sales Growth 4.5 Middle East & Africa Pneumococcal Vaccine Sales Growth 5 Americas 5.1 Americas Pneumococcal Vaccine Sales by Country 5.1.1 Americas Pneumococcal Vaccine Sales by Country (2016-2021) 5.1.2 Americas Pneumococcal Vaccine Revenue by Country (2016-2021) 5.2 Americas Pneumococcal Vaccine Sales by Type 5.3 Americas Pneumococcal Vaccine Sales by End User 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Pneumococcal Vaccine Sales by Region 6.1.1 APAC Pneumococcal Vaccine Sales by Region (2016-2021) 6.1.2 APAC Pneumococcal Vaccine Revenue by Region (2016-2021) 6.2 APAC Pneumococcal Vaccine Sales by Type 6.3 APAC Pneumococcal Vaccine Sales by End User 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Pneumococcal Vaccine by Country 7.1.1 Europe Pneumococcal Vaccine Sales by Country (2016-2021) 7.1.2 Europe Pneumococcal Vaccine Revenue by Country (2016-2021) 7.2 Europe Pneumococcal Vaccine Sales by Type 7.3 Europe Pneumococcal Vaccine Sales by End User 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Pneumococcal Vaccine by Country 8.1.1 Middle East & Africa Pneumococcal Vaccine Sales by Country (2016-2021) 8.1.2 Middle East & Africa Pneumococcal Vaccine Revenue by Country (2016-2021) 8.2 Middle East & Africa Pneumococcal Vaccine Sales by Type 8.3 Middle East & Africa Pneumococcal Vaccine Sales by End User 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Pneumococcal Vaccine Distributors 10.3 Pneumococcal Vaccine Customer 11 Global Pneumococcal Vaccine Market Forecast 11.1 Global Pneumococcal Vaccine Forecast by Region 11.1.1 Global Pneumococcal Vaccine Forecast by Regions (2021-2026) 11.2.2 Global Pneumococcal Vaccine Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Pneumococcal Vaccine Forecast by Type 11.7 Global Pneumococcal Vaccine Forecast by End User 12 Key Players Analysis 12.1 Pfizer 12.1.1 Pfizer Company Information 12.1.2 Pfizer Pneumococcal Vaccine Product Offered 12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Pfizer Main Business Overview 12.1.5 Pfizer Latest Developments 12.2 GSK 12.2.1 GSK Company Information 12.2.2 GSK Pneumococcal Vaccine Product Offered 12.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 GSK Main Business Overview 12.2.5 GSK Latest Developments 12.3 MSD 12.3.1 MSD Company Information 12.3.2 MSD Pneumococcal Vaccine Product Offered 12.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 MSD Main Business Overview 12.3.5 MSD Latest Developments 12.4 Sanofipasteur 12.4.1 Sanofipasteur Company Information 12.4.2 Sanofipasteur Pneumococcal Vaccine Product Offered 12.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 Sanofipasteur Main Business Overview 12.4.5 Sanofipasteur Latest Developments 12.5 CDIBP 12.5.1 CDIBP Company Information 12.5.2 CDIBP Pneumococcal Vaccine Product Offered 12.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 CDIBP Main Business Overview 12.5.5 CDIBP Latest Developments ... 13 Research Findings and Conclusion

List of Tables Table 1. Pneumococcal Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of PPSV 23 Table 3. Major Players of PCV 7/13 Table 4. Major Players of PCV 10 Table 5. Global Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses) Table 6. Global Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 7. Global Pneumococcal Vaccine Revenue by Type (2016-2021) & ($ million) Table 8. Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2021) Table 9. Global Pneumococcal Vaccine Sale Price by Type (2016-2021) Table 10. Global Pneumococcal Vaccine Sales by End User (2016-2021) & (K Doses) Table 11. Global Pneumococcal Vaccine Sales Market Share by End User (2016-2021) Table 12. Global Pneumococcal Vaccine Value by End User (2016-2021) Table 13. Global Pneumococcal Vaccine Revenue Market Share by End User (2016-2021) Table 14. Global Pneumococcal Vaccine Sale Price by End User (2016-2021) Table 15. Global Pneumococcal Vaccine Sales by Company (2019-2021) & (K Doses) Table 16. Global Pneumococcal Vaccine Sales Market Share by Company (2019-2021) Table 17. Global Pneumococcal Vaccine Revenue by Company (2019-2021) ($ Millions) Table 18. Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2021) Table 19. Global Pneumococcal Vaccine Sale Price by Company (2019-2021) Table 20. Key Manufacturers Pneumococcal Vaccine Producing Area Distribution and Sales Area Table 21. Players Pneumococcal Vaccine Products Offered Table 22. Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Pneumococcal Vaccine Sales by Region (2016-2021) (K Doses) Table 26. Global Pneumococcal Vaccine Sales Market Share by Region (2016-2021) Table 27. Global Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Pneumococcal Vaccine Revenue Market Share by Region (2016-2021) Table 29. Americas Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses) Table 30. Americas Pneumococcal Vaccine Sales Market Share by Country (2016-2021) Table 31. Americas Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Pneumococcal Vaccine Revenue Market Share by Country (2016-2021) Table 33. Americas Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses) Table 34. Americas Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 35. Americas Pneumococcal Vaccine Sales by End User (2016-2021) & (K Doses) Table 36. Americas Pneumococcal Vaccine Sales Market Share by End User (2016-2021) Table 37. APAC Pneumococcal Vaccine Sales by Region (2016-2021) & (K Doses) Table 38. APAC Pneumococcal Vaccine Sales Market Share by Region (2016-2021) Table 39. APAC Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Pneumococcal Vaccine Revenue Market Share by Region (2016-2021) Table 41. APAC Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses) Table 42. APAC Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 43. APAC Pneumococcal Vaccine Sales by End User (2016-2021) & (K Doses) Table 44. APAC Pneumococcal Vaccine Sales Market Share by End User (2016-2021) Table 45. Europe Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses) Table 46. Europe Pneumococcal Vaccine Sales Market Share by Country (2016-2021) Table 47. Europe Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Pneumococcal Vaccine Revenue Market Share by Country (2016-2021) Table 49. Europe Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses) Table 50. Europe Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 51. Europe Pneumococcal Vaccine Sales by End User (2016-2021) & (K Doses) Table 52. Europe Pneumococcal Vaccine Sales Market Share by End User (2016-2021) Table 53. Middle East & Africa Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses) Table 54. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses) Table 58. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa Pneumococcal Vaccine Sales by End User (2016-2021) & (K Doses) Table 60. Middle East & Africa Pneumococcal Vaccine Sales Market Share by End User (2016-2021) Table 61. Key and Potential Regions of Pneumococcal Vaccine Table 62. Key Application and Potential Industries of Pneumococcal Vaccine Table 63. Key Challenges of Pneumococcal Vaccine Table 64. Key Trends of Pneumococcal Vaccine Table 65. Pneumococcal Vaccine Distributors List Table 66. Pneumococcal Vaccine Customer List Table 67. Global Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Doses) Table 68. Global Pneumococcal Vaccine Consumption Market Forecast by Region Table 69. Global Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 70. Global Pneumococcal Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 71. Americas Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses) Table 72. Americas Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 73. APAC Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Doses) Table 74. APAC Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 75. Europe Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses) Table 76. Europe Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. Middle East & Africa Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses) Table 78. Middle East & Africa Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Global Pneumococcal Vaccine Sales Forecast by Type (2021-2026) & (K Doses) Table 80. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2021-2026) Table 81. Global Pneumococcal Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions) Table 82. Global Pneumococcal Vaccine Revenue Market Share Forecast by Type (2021-2026) Table 83. Global Pneumococcal Vaccine Sales Forecast by End User (2021-2026) & (K Doses) Table 84. Global Pneumococcal Vaccine Sales Market Share Forecast by End User (2021-2026) Table 85. Global Pneumococcal Vaccine Revenue Forecast by End User (2021-2026) & ($ Millions) Table 86. Global Pneumococcal Vaccine Revenue Market Share Forecast by End User (2021-2026) Table 87. Pfizer Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 88. Pfizer Pneumococcal Vaccine Product Offered Table 89. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 90. Pfizer Main Business Table 91. Pfizer Latest Developments Table 92. GSK Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 93. GSK Pneumococcal Vaccine Product Offered Table 94. GSK Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 95. GSK Main Business Table 96. GSK Latest Developments Table 97. MSD Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 98. MSD Pneumococcal Vaccine Product Offered Table 99. MSD Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 100. MSD Main Business Table 101. MSD Latest Developments Table 102. Sanofipasteur Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 103. Sanofipasteur Pneumococcal Vaccine Product Offered Table 104. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 105. Sanofipasteur Main Business Table 106. Sanofipasteur Latest Developments Table 107. CDIBP Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 108. CDIBP Pneumococcal Vaccine Product Offered Table 109. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 110. CDIBP Main Business Table 111. CDIBP Latest Developments List of Figures Figure 1. Picture of Pneumococcal Vaccine Figure 2. Pneumococcal Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Pneumococcal Vaccine Sales Growth Rate 2016-2026 (K Doses) Figure 7. Global Pneumococcal Vaccine Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Pneumococcal Vaccine Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of PPSV 23 Figure 10. Product Picture of PCV 7/13 Figure 11. Product Picture of PCV 10 Figure 12. Global Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 13. Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2021) Figure 14. Pneumococcal Vaccine Consumed in Child Figure 15. Global Pneumococcal Vaccine Market: Child (2016-2021) & (K Doses) Figure 16. Pneumococcal Vaccine Consumed in Adult Figure 17. Global Pneumococcal Vaccine Market: Adult (2016-2021) & (K Doses) Figure 18. Global Pneumococcal Vaccine Sales Market Share by End User (2016-2021) Figure 19. Global Pneumococcal Vaccine Revenue Market Share by End User in 2020 Figure 20. Pneumococcal Vaccine Revenue Market by Company in 2020 ($ Million) Figure 21. Global Pneumococcal Vaccine Revenue Market Share by Company in 2020 Figure 22. Global Pneumococcal Vaccine Sales Market Share by Regions (2016-2021) Figure 23. Global Pneumococcal Vaccine Revenue Market Share by Region in 2020 Figure 24. Americas Pneumococcal Vaccine Sales 2016-2021 (K Doses) Figure 25. Americas Pneumococcal Vaccine Revenue 2016-2021 ($ Millions) Figure 26. APAC Pneumococcal Vaccine Sales 2016-2021 (K Doses) Figure 27. APAC Pneumococcal Vaccine Revenue 2016-2021 ($ Millions) Figure 28. Europe Pneumococcal Vaccine Sales 2016-2021 (K Doses) Figure 29. Europe Pneumococcal Vaccine Revenue 2016-2021 ($ Millions) Figure 30. Middle East & Africa Pneumococcal Vaccine Sales 2016-2021 (K Doses) Figure 31. Middle East & Africa Pneumococcal Vaccine Revenue 2016-2021 ($ Millions) Figure 32. Americas Pneumococcal Vaccine Sales Market Share by Country in 2020 Figure 33. Americas Pneumococcal Vaccine Revenue Market Share by Country in 2020 Figure 34. Americas Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 35. Americas Pneumococcal Vaccine Sales Market Share by End User in 2020 Figure 36. United States Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 37. Canada Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 38. Mexico Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 39. Brazil Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 40. APAC Pneumococcal Vaccine Sales Market Share by Region in 2020 Figure 41. APAC Pneumococcal Vaccine Revenue Market Share by Regions in 2020 Figure 42. APAC Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 43. APAC Pneumococcal Vaccine Sales Market Share by End User in 2020 Figure 44. China Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 45. Japan Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 46. Korea Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 47. Southeast Asia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 48. India Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 49. Australia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 50. Europe Pneumococcal Vaccine Sales Market Share by Country in 2020 Figure 51. Europe Pneumococcal Vaccine Revenue Market Share by Country in 2020 Figure 52. Europe Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 53. Europe Pneumococcal Vaccine Sales Market Share by End User in 2020 Figure 54. Germany Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 55. France Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 56. UK Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 57. Italy Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 58. Russia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 59. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country in 2020 Figure 60. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country in 2020 Figure 61. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 62. Middle East & Africa Pneumococcal Vaccine Sales Market Share by End User in 2020 Figure 63. Egypt Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 64. South Africa Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 65. Israel Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 66. Turkey Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 67. GCC Country Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 68. Channels of Distribution Figure 69. Distributors Profiles